Huntington National Bank Biotechnology

Huntington National Bank

$13.8 Billion
Q4 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
IDYA Ideaya Biosciences, Inc.	$1.01B	$2,000 0.0% of portfolio	97	Q4 2024 New
RVMD Revolution Medicines, Inc.	$3.57B	$2,000 0.0% of portfolio	66	Q4 2024 New
ARVN Arvinas, Inc.	$974M	$1,000 0.0% of portfolio	78	Q4 2024 Reduced 15.22%
CORT Corcept Therapeutics Inc	$7.79B	$1,000 0.0% of portfolio	29	Q2 2024 Added 163.64%
JANX Janux Therapeutics, Inc.	$1.52B	$1,000 0.0% of portfolio	24	Q4 2024 Reduced 41.46%
SRNE Sorrento Therapeutics, Inc.	$148M	$1,000 0.0% of portfolio	5,001	Q4 2023 Reduced 66.66%
ADPT Adaptive Biotechnologies Corp	$1.19B	$0 0.0% of portfolio	1	Q4 2023 Reduced 99.81%
AIM Aim Immuno Tech Inc.	$6.25M	$0 0.0% of portfolio	57	Q4 2019 New
ALBO Albireo Pharma, Inc.	$0	$0 0.0% of portfolio	1	Q1 2023 Reduced 99.88%
ALLO Allogene Therapeutics, Inc.	$293M	$0 0.0% of portfolio	451	Q4 2024 Added 0.45%
ALT Altimmune, Inc.	$312M	$0 0.0% of portfolio	2	Q3 2023 Reduced 99.89%
AUPH Aurinia Pharmaceuticals Inc.	$1.11B	$0 0.0% of portfolio	2	Q2 2023 Reduced 99.68%
AUTL Autolus Therapeutics PLC	$185M	$0 0.0% of portfolio	1	Q2 2023 Reduced 99.93%
BGNE Bei Gene, Ltd.	$23.5B	$0 0.0% of portfolio	5	Q4 2024 Added 400.0%
BBIO Bridge Bio Pharma, Inc.	$5.17B	$0 0.0% of portfolio	1	Q4 2024 New
CVM Cel Sci Corp	$18.2M	$0 0.0% of portfolio	500	Q2 2023 New
APOP Cellect Biotechnology Ltd.	$51.5M	$0 0.0% of portfolio	-	Q3 2021 New
CDXS Codexis, Inc.	$282M	$0 0.0% of portfolio	2	Q3 2023 Reduced 99.88%
CHRS Coherus Bio Sciences, Inc.	$91.7M	$0 0.0% of portfolio	1	Q4 2021 New
GBIO Generation Bio Co.	$40.1M	$0 0.0% of portfolio	1	Q3 2021 Reduced 99.52%
GBT Global Blood Therapeutics, Inc.	$4.62B	$0 0.0% of portfolio	1	Q4 2022 Reduced 99.55%
HTBX Heat Biologics, Inc.	$60.5M	$0 0.0% of portfolio	1	Q4 2020 Reduced 90.91%
HRTX Heron Therapeutics, Inc.	$211M	$0 0.0% of portfolio	370	Q4 2024 Reduced 69.4%
IMGN Immuno Gen, Inc.	$0	$0 0.0% of portfolio	1	Q1 2024 Reduced 98.31%
NKTR Nektar Therapeutics	$184M	$0 0.0% of portfolio	1	Q1 2020 Reduced 99.88%
OMGA Omega Therapeutics, Inc.	$11M	$0 0.0% of portfolio	1	Q4 2023 New
ORMP Oramed Pharmaceuticals Inc.	$93.2M	$0 0.0% of portfolio	2	Q3 2024 Reduced 99.96%
OYST Oyster Point Pharma, Inc.	$0	$0 0.0% of portfolio	1	Q1 2023 Reduced 99.89%
PTGX Protagonist Therapeutics, Inc	$1.9B	$0 0.0% of portfolio	5	Q4 2024 New
PVCT Provectus Biopharmaceuticals, Inc.	$41.9M	$0 0.0% of portfolio	1	Q2 2019 New
RIGL Rigel Pharmaceuticals Inc	$3.73B	$0 0.0% of portfolio	1	Q2 2024 Reduced 99.81%
SAGE Sage Therapeutics, Inc.	$424M	$0 0.0% of portfolio	1	Q2 2024 Reduced 98.97%
SRRK Scholar Rock Holding Corp	$1.91B	$0 0.0% of portfolio	15	Q4 2024 New
TARS Tarsus Pharmaceuticals, Inc.	$1.34B	$0 0.0% of portfolio	1	Q1 2024 Reduced 99.93%
VERU Veru Inc.	$43.3M	$0 0.0% of portfolio	1	Q4 2021 New
VIR Vir Biotechnology, Inc.	$1.28B	$0 0.0% of portfolio	33	Q4 2024 Reduced 17.5%
MYOV Myovant Sciences Ltd.	$0	$0 0.0% of portfolio	1	Q4 2021 New
PRTA Prothena Corp Public LTD CO	$665M	$0 0.0% of portfolio	34	Q4 2024 New
ROIV Roivant Sciences Ltd.	$7.44B	$0 0.0% of portfolio	48	Q4 2024 Added 14.29%
TBPH Theravance Biopharma, Inc.	$642M	$0 0.0% of portfolio	50	Q4 2024 Reduced 63.77%
CRSP Crispr Therapeutics Ag	$3.88B	$0 0.0% of portfolio	17	Q4 2024 Reduced 94.41%
IMTX Immatics N.V.	$385M	$0 0.0% of portfolio	1	Q3 2024 Reduced 99.86%
QURE Uni Qure N.V.	$663M	$0 0.0% of portfolio	2	Q1 2022 Reduced 99.28%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.